Benzinga | Aug 6, 2020 05:36PM EDT

Accelerate Diagnostics Q2 EPS $(0.35) Misses $(0.34) Estimate, Sales $2.13M Miss $2.46M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 2.94 percent. This is a 7.89 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $2.13 million which missed the analyst consensus estimate of $2.46 million by 13.62 percent. This is a 17.66 percent increase over sales of $1.81 million the same period last year.